Since 2004, we have been dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of new therapies for neurological diseases through the application of medical image analysis and digital health technologies, bringing safe and effective treatment to patients sooner. We are committed to advancing imaging biomarkers in CNS therapeutic areas such as Huntington’s disease, Parkinson’s disease and Alzheimer’s disease.
Alzheimer’s disease, for example, affects over 50 million people worldwide with devastating emotional and financial impact on patients and families. With no disease modifying therapies and 99.6% failure rate in drug development, Alzheimer’s disease remains an acute area of unmet need in clinical research. IXICO teams are relentlessly focused on advancing medicine and human health through cutting edge neuroscience and breakthrough AI technologies to support potential therapies in neurological and neurodegenerative disorders.
We are specialist experts in neuroimaging data analysis. We are continually recruiting the best minds in the industry whose knowledge is at the cutting edge of clinical and technology advancement.
We never stop striving to innovate, improve and advance clinical research into neurodegenerative diseases. Our greatest assets are the talented people who are continually developing, evolving, and deploying our innovative AI and digital technologies.
Our commitment to the highest standards drives our operational excellence. We ensure everything we do is fully backed by utmost quality and compliance. We support our people to be the best they can be through continuous learning and development.
We conduct our business to the highest ethical standards and aim to be the trusted partner of choice for CNS clinical trials. We pride ourselves on the strong relationships we build with our clients as well as the exceptional work we deliver.
King's College Partnership
IXICO was chosen as partner for King's College London's UK Government-funded Medical Imaging & Artificial Intelligence Centre
Oversubscribed placing of £5.5m to invest in new product and new market development
Digital biomarkers commercial collaboration
The arrival of connected digital technologies (wearable biosensors and mobile devices) that enable the passive measurement of parameters such as sleep, activity and heart rate outside of the clinic, has provided the opportunity to revolutionize the capture of data in clinical trials.
Post-marketing surveillance commercial collaboration
IXICO are partnering with pharma companies to develop digital clinical decision support technologies based on our Assessa platform technology to improve the targeting and the safety and effectiveness of their therapeutics.
Assessa platform launched
The clinical decision support platform, Assessa provides access to expert neuroradiologists for a standardized radiological read, and securely captures then transfers clinical data and MR images from referring neurologists to expert neuroradiologists.
IXICO was listed on the Alternative Investment Market (AIM), a sub-market of the London Stock Exchange (LSE).
Web-based TrialTracker platform launched
The TrialTrackerTM data managment platform is a secure and compliant environment for the collection, analysis and interpretation of large image files and other data that may be generated in the course of a clinical study.
First Phase 3 trial
IXICO is awarded it's first Phase 3 study for Alzheimer's disease.
Clinical trial platform launched
IXICO provides neuroscience expertise and global operations to deliver imaging and digital biomarker analytical services for clinical development, within a framework of regulatory compliance.
A spin-out from London universities' ‘Information eXtraction from Images’ project.
Collaboration within clinical research is key to advancing treatments for neurological diseases. Working with partners in academia, business and charitable organisations, we help further the international scientific and regulatory agenda. We provide access to our platform and advanced data analysis for more accurate and applicable insights that further neurological research. We are also working with partners to develop new analytical techniques and digital health products to improve patient outcomes.
Careers at IXICO
Our team of scientists, researchers, quality professionals, and business people are passionate about their role in advancing neurological research – it’s what gets us out of bed. We work with incredible partners in biopharmaceuticals, academic institutions and clinical research sites around the world. Are you an innovator on the cutting edge of clinical research and technologies? Get in touch today.